Beyond PAP: Oral Appliances, Position, Weight, Surgery, and Combination Therapy

Opening Clinical Case

A patient with moderate positional OSA, retrognathia, and marked PAP intolerance asks whether an oral appliance is “basically the same thing as CPAP.” It is not the same thing, but it can be a legitimate alternative or adjunct depending on the patient’s anatomy, preferences, and goals. This chapter is about matching the treatment to the problem rather than pretending every therapy is interchangeable.aasm+1

The main lesson is that PAP is not the only path, but alternatives are also not universal substitutes. Oral appliances, positional therapy, weight treatment, surgery, hypoglossal nerve stimulation, and combination strategies each have a place, each has limitations, and each needs follow-up testing or reassessment. Good sleep medicine is less about allegiance to one therapy and more about choosing the right one for the right patient.aasm+2

What You Should Be Able to Do After This Chapter

By the end of this chapter, you should be able to:

• Identify appropriate candidates for oral appliance therapy.

• Recognize when positional therapy is useful and when it is not enough.

• Discuss weight management as part of OSA care without moralizing it.

• Understand the current role of tirzepatide in eligible adults with obesity and OSA.

• Know when to consider surgical referral or hypoglossal nerve stimulation.

• Combine therapies rationally rather than treating them as mutually exclusive.

• Ensure objective follow-up after an alternative or adjunctive therapy is started.

The Core Concept

Different OSA treatments work by different mechanisms. PAP pneumatically splints the airway. Oral appliances advance the mandible and may enlarge the retroglossal space. Positional therapy reduces supine vulnerability. Weight treatment reduces obesity-related airway burden. Surgery changes anatomy. Hypoglossal nerve stimulation supports upper-airway muscle tone during sleep. Some patients need one of these; others need combinations.aasm+2

Medical explanation: treatment selection should match the mechanism, the phenotype, and the patient’s preferences and feasibility. Explain It Like I’m 10: some airways behave badly mainly on the back, some need more room behind the tongue, and some need help because extra tissue or body weight is crowding the airway. Different problems need different fixes. Back to clinical medicine: the right question is not “Which treatment is best?” but “Which treatment fits this patient’s problem best?”

A structured comparison makes the main choices easier to remember.

Oral-Appliance Therapy

Oral-appliance therapy uses mandibular advancement to move the lower jaw forward and increase the space behind the tongue. The AASM/AADSM guideline supports a custom, titratable oral appliance for appropriate adults with OSA who are intolerant of CPAP or prefer an alternative, with qualified dental oversight and follow-up testing. That combination is important: custom, titratable, and followed over time. A generic device bought without proper oversight is not the same thing.aasm+1

This treatment is often a good fit for patients with PAP intolerance, mild-to-moderate OSA, retrognathia, or strong preference for a non-PAP option. It is not universally equivalent to PAP, and efficacy can vary. Dental and temporomandibular issues matter, because jaw positioning can affect bite, teeth, and comfort. Follow-up testing matters because the appliance should not be judged only by snoring reduction or subjective enthusiasm.

Explain It Like I’m 10: the device gently moves the lower jaw forward, which may create more room behind the tongue and reduce airway collapse. Back to clinical medicine: oral appliance therapy is a legitimate alternative for selected adults, but it needs dental oversight and objective follow-up.aasm+1

Positional Therapy

Positional therapy is for patients whose OSA is clearly worse on the back than on the side. Some airways are cooperative laterally and troublesome supine. Positional therapy tries to keep the patient out of the trouble position. It can be useful when supine dependence is documented and nonsupine breathing is substantially better.aasm

The limitation is durability. Patients may stop using positional devices, migrate back onto their backs during sleep, or have disease that is not truly positional once you sample enough sleep. Limited nonsupine sleep can mislead, because sparse side-sleep data can make a patient look more positional than they really are. Follow-up testing helps confirm whether the strategy is actually working. If the position data are weak, be careful about calling the disease “positional” with too much confidence.aasm

Explain It Like I’m 10: some airways behave well on the side and badly on the back. Positional therapy tries to keep the patient out of the trouble position. Back to clinical medicine: positional therapy is most useful when positional dependence is documented and should not be assumed from a small amount of data.

Weight Management

Weight is a clinical contributor, not a moral failing. Weight management can improve OSA by reducing airway load, soft-tissue burden, and obesity-related physiologic contributors. Lifestyle intervention, multidisciplinary obesity treatment, pharmacotherapy, and bariatric-surgery referral may all be relevant depending on the patient. Weight management often occurs alongside airway therapy rather than instead of it.fda+1

A major point for fellows is that weight treatment should not be used as a reason to withhold immediate airway therapy when the patient needs it now. Reassessment after major weight change is important because OSA severity can change meaningfully. But “lose weight” is not a complete sleep apnea plan. It is one component of one plan.

Tirzepatide and OSA

Tirzepatide, marketed as Zepbound, received FDA approval on December 20, 2024, for moderate-to-severe OSA in adults with obesity, in combination with reduced-calorie intake and increased physical activity. The benefit appears to be largely related to weight reduction, which decreases tissue burden around the airway and improves OSA severity. This is important because it gives eligible patients an additional evidence-based option.jamanetwork+2

Tirzepatide is not an air splint. It is not a universal treatment for every patient with OSA. It has contraindications, warnings, and adverse effects like any other medication, and it should be considered in the context of obesity and the broader metabolic picture. Also, do not stop effective PAP just because a weight-loss medication has started. If PAP is working, it is still working; a new medication does not magically replace it on day one.fda

Explain It Like I’m 10: tirzepatide is not an air splint. In eligible adults with obesity, it can improve OSA mainly by helping reduce weight and airway burden.fda Back to clinical medicine: medication-related OSA improvement is real, but it is not a replacement for thoughtful airway management.

Upper-Airway Surgery

Surgery should be discussed as a treatment option, not promised as a miracle. AASM guidance supports referral for surgical consultation in selected adults with OSA, including those intolerant of or unaccepting of PAP and those with relevant body habitus or anatomical considerations. The surgical conversation should be anatomical and realistic. Uvulopalatopharyngoplasty, maxillomandibular advancement, nasal procedures, and other interventions all have different roles and different success patterns.assets.ctfassets+2

The key is that outcomes vary. Surgery is not a guaranteed cure, and many patients still need adjunctive therapy afterward. Some procedures reduce pressure needs rather than eliminate OSA entirely. Nasal surgery may improve PAP tolerance more than it cures OSA outright. If a patient wants certainty, this is the wrong specialty for pretending certainty exists where it does not.

Hypoglossal Nerve Stimulation

Hypoglossal nerve stimulation helps activate upper-airway muscles during sleep so the tongue and airway remain more stable. It is not “the tongue gets shocked every time the patient snores,” which is a common oversimplification. Proper selection, anatomical evaluation, implantation, activation, titration, and follow-up testing are all part of the process. It is a device-based therapy for carefully selected patients, not a universal replacement for PAP.aasm+1

The eligibility rules are not simplistic, and the patient-selection process matters. Some patients who cannot tolerate PAP may be candidates, but selection depends on anatomy, severity, and clinical context. As with other advanced therapies, it is important not to flatten the nuance into a one-line rule. In sleep medicine, that kind of flattening usually backfires.

Myofunctional and Adjunctive Therapies

Myofunctional exercises, nasal treatment, alcohol counseling, sedative review, exercise, and other adjunctive strategies can help in selected patients, but they are not proven universal cures. They are best thought of as supportive measures or combination tools rather than standalone guarantees. If the patient drinks alcohol at bedtime, has untreated rhinitis, or uses sedating medications, those issues can worsen OSA or undermine other treatments.

The value of adjunctive therapy is often in the combination. A nasal problem can make PAP harder. Alcohol can worsen collapsibility. Exercise can support weight reduction and cardiometabolic health. But unsupported cure claims should be avoided. If something sounds too easy, it probably is.

Combining Treatments

Combining treatments is often smarter than forcing a single modality to do everything. Oral appliance plus positional therapy can be reasonable in positional disease. PAP plus weight management may improve control and reduce pressure needs. Surgery plus PAP can lower required pressures and improve tolerance. Nasal treatment plus PAP can reduce leak and improve comfort.fda+2

The point is not that combination therapy is glamorous. It is that some patients need layered solutions. OSA is often multifactorial: anatomy, body habitus, position, nasal airflow, and behavioral factors all contribute. Matching the combination to the phenotype is good medicine.

Practical combination examples

• Oral appliance plus positional therapy for positional disease with PAP intolerance.

• PAP plus weight management for obesity-associated OSA.

• Surgery plus PAP when surgery reduces but does not eliminate disease.

• Nasal treatment plus PAP when nasal obstruction is undermining tolerance.

• Weight treatment plus continued airway therapy when OSA remains clinically relevant.

Diagnostic Reasoning

The diagnostic move is to identify the dominant phenotype and the treatment barrier. If the patient has PAP intolerance and retrognathia, oral appliance therapy becomes reasonable. If the disease is clearly supine-predominant, positional therapy may help, especially if the nonsupine data are robust. If obesity is a major contributor, weight treatment should be part of the plan. If anatomy is prominent or PAP is not acceptable, surgical consultation or hypoglossal nerve stimulation may be appropriate.assets.ctfassets+3

That said, alternative therapy does not mean no follow-up. The diagnosis has not been “solved” just because a different treatment was chosen. Objective reassessment matters because symptom improvement alone can be misleading. This is the chapter’s recurring theme: do not replace one dogma with another.

Understanding the Relevant Data

Each alternative treatment needs objective follow-up. Oral appliances need dental review and sleep testing. Positional therapy needs reassessment because adherence and positional dependence can drift over time. Weight treatment needs reassessment after major change. Surgery and hypoglossal nerve stimulation need specialist follow-up and objective testing. If you start an alternative therapy without checking its effect, you are running on hope.aasm+3

The wrong fallback is oxygen. Oxygen may improve desaturation, but it does not fix airway obstruction and should not be used as a substitute for treating OSA. That is a board-trap for a reason. Oxygen can change the numbers while leaving the physiology behind.

Return to the Opening Case

A patient with moderate positional OSA, retrognathia, and marked PAP intolerance is a classic candidate to discuss a custom titratable oral appliance, especially if the patient prefers a non-PAP approach. If supine dependence is robust, positional therapy may be added. If obesity is present, weight management should be part of the plan. If anatomy or severity suggests it, surgical consultation or hypoglossal nerve stimulation may enter the conversation. The treatment should not be framed as “oral appliance is basically the same as CPAP,” because it is not.aasm+1

The correct message is more nuanced and more useful. Oral appliance therapy may be a very reasonable alternative, but it has its own mechanism, its own limitations, and its own monitoring needs. If you explain that clearly, patients usually understand it better than clinicians expect.

What the Attending Will Ask

1. Is an oral appliance basically the same as CPAP? No. It is a different mechanism with different efficacy and follow-up needs.aasm+1

1. Who is a good oral-appliance candidate? An adult with OSA who is intolerant of CPAP or prefers an alternative, ideally with a custom titratable device and dental oversight.aasm+1

1. When is positional therapy useful? When OSA is clearly supine-predominant and positional dependence is documented.aasm

1. Does weight loss cure everyone? No. It can improve OSA, but resolution is variable and reassessment is needed.fda

1. What is tirzepatide’s OSA role? In adults with obesity and moderate-to-severe OSA, alongside reduced-calorie intake and increased physical activity.fda

1. Should PAP be stopped when tirzepatide starts? No. If PAP is effective, it should not be stopped solely because medication begins.

1. When should surgical consultation be discussed? In selected adults who are intolerant of or unaccepting of PAP, or who have relevant anatomic or body-habitus factors.aasm+2

1. Why is objective follow-up necessary? Because symptoms alone can mislead, and alternative therapies need confirmation of effect.

Mistakes Smart Fellows Still Make

1. Treating oral appliances as universally equivalent to PAP. This happens because both are “treatments.” It matters because efficacy differs. Avoid it by matching therapy to phenotype and preference.

1. Using oxygen as a substitute for treating obstruction. This happens because desaturation looks important. It matters because obstruction remains untreated. Avoid it by treating the airway problem directly.

1. Assuming weight loss guarantees cure. This happens because weight is a visible risk factor. It matters because OSA can persist even after major weight change. Avoid it by reassessing objectively.

1. Promising surgical success. This happens because patients want certainty. It matters because outcomes vary widely. Avoid it by discussing likely benefit, not guaranteed cure.

1. Starting an alternative therapy without objective follow-up. This happens because the new plan feels complete. It matters because effectiveness may be unclear. Avoid it by scheduling reassessment and testing.

The Board Exam Is Trying to Trick You

1. The question asks whether oral appliance therapy is the same as CPAP. The trap is to say yes because both treat OSA. The correct answer is no; they work differently and have different efficacy and monitoring requirements.aasm+1

1. The stem gives positional OSA. The trap is to ignore positional therapy. The correct answer is to consider it when positional dependence is documented.aasm

1. The stem gives obesity and OSA and asks about weight loss. The trap is to treat weight management as a moral statement instead of a therapy. The correct answer is that weight treatment can be part of care, often alongside airway therapy.

1. The question mentions tirzepatide. The trap is to assume it replaces PAP. The correct answer is that it is an adjunct or alternative for eligible adults with obesity, not an automatic substitute.fda

1. The stem offers surgery. The trap is to promise cure. The correct answer is to discuss consultation for selected patients and acknowledge variable outcomes.assets.ctfassets+2

How to Explain This to a Patient

“CPAP is one very effective way to treat sleep apnea, but it is not the only way. An oral appliance works differently by moving your jaw forward. Positional therapy helps if your breathing is mainly worse on your back. Weight treatment can improve the underlying airway burden, and in selected patients there are surgical or implanted options. The best plan depends on what is causing your sleep apnea and what you can realistically use.”

Practical Pearls

• Oral appliance therapy is a real alternative for selected adults, not a CPAP clone.aasm+1

• Positional therapy is most useful when supine dependence is documented.

• Weight management should be part of OSA care, not a moral lecture.

• Tirzepatide is FDA-approved for moderate-to-severe OSA in adults with obesity, with diet and exercise.fda

• PAP should not be stopped just because weight-loss medication starts.

• Surgical referral is appropriate in selected patients, especially PAP-intolerant individuals.aasm+2

• Hypoglossal nerve stimulation is for carefully selected patients and is not a universal rule-based shortcut.

• Combination therapy is often the smartest plan.

• Objective follow-up is required after any alternative or adjunctive therapy.

• Oxygen is not a substitute for treating obstruction.

The Bottom Line

• Alternatives to PAP are legitimate, but they are not interchangeable.

• Oral appliance therapy is appropriate for selected adults who are PAP-intolerant or prefer an alternative, with dental oversight and follow-up testing.aasm+1

• Positional therapy helps when OSA is truly positional.aasm

• Weight management is an important part of OSA care and may include pharmacotherapy or bariatric referral.fda

• Tirzepatide is FDA-approved for moderate-to-severe OSA in adults with obesity, alongside calorie reduction and exercise.fda

• Surgical consultation should be discussed in selected PAP-intolerant or anatomically appropriate patients.assets.ctfassets+2

• Hypoglossal nerve stimulation and surgery require careful selection and follow-up.

• Combination therapy is often better than single-modality thinking.

• Objective reassessment is required after starting an alternative therapy.

• The best treatment is the one that fits the patient and actually gets used.

Question 1

A patient with moderate OSA and retrognathia cannot tolerate PAP and prefers a non-PAP treatment. What is a reasonable next discussion?

A. Oral appliance therapy with qualified dental oversight B. Oxygen alone C. No treatment needed D. Repeat the same PAP prescription without changes E. Assuming cure because the patient wants an alternative

Question 2

Which statement about oral appliance therapy is most accurate?

A. It is universally equivalent to CPAP B. It should be custom and titratable with follow-up testing C. It never affects the teeth or jaw D. It does not require dental oversight E. It should never be used in OSA

Question 3

When is positional therapy most likely to help?

A. When OSA is clearly worse supine than nonsupine B. In all patients regardless of sleep position C. Only in central sleep apnea D. Only after surgery fails E. Only when the AHI is zero

Question 4

What is the most accurate statement about tirzepatide in OSA?

A. It is an air splint like CPAP B. It is FDA-approved for moderate-to-severe OSA in adults with obesity, with diet and exercise C. It replaces all other OSA treatments immediately D. It is for every patient with snoring E. It works by tightening the throat muscles directly during sleep

Question 5

Why is objective follow-up important after surgery, oral appliance therapy, or positional therapy?

A. Because symptoms alone can be misleading B. Because every alternative therapy cures everyone C. Because follow-up is only for billing D. Because treatment never changes after the first choice E. Because objective testing is unnecessary once a therapy is chosen

Question 1

Correct answer: A. Oral appliance therapy with qualified dental oversight.

Why it is correct: the AASM/AADSM guideline supports oral appliance therapy for adults with OSA who are intolerant of CPAP or prefer an alternative.aasm+1 Why the others are wrong: B treats the wrong problem, C is unsafe, D ignores intolerance, and E is unsupported. Learning point: a non-PAP preference can be legitimate when matched with the right device and follow-up.

Question 2

Correct answer: B. It should be custom and titratable with follow-up testing.

Why it is correct: that is the guideline-supported approach.aasm+1 Why the others are wrong: A, C, D, and E are incorrect or misleading. Learning point: oral appliance therapy is a monitored treatment, not a casual accessory.

Question 3

Correct answer: A. When OSA is clearly worse supine than nonsupine.

Why it is correct: positional therapy targets supine vulnerability.aasm Why the others are wrong: B is false, C is wrong physiology, D is not required, and E is nonsensical. Learning point: positional therapy requires documented positional dependence.

Question 4

Correct answer: B. It is FDA-approved for moderate-to-severe OSA in adults with obesity, with diet and exercise.

Why it is correct: that is the approved indication and context.fda Why the others are wrong: A, C, D, and E are false. Learning point: tirzepatide is an obesity-related OSA therapy, not an airway splint.

Question 5

Correct answer: A. Because symptoms alone can be misleading.

Why it is correct: objective testing helps confirm that the therapy actually worked. Why the others are wrong: B, C, D, and E are false. Learning point: follow-up is required after alternative therapy.